Free for academic non-profit institutions. Other users need a Commercial license
The protein encoded by this gene is a member of the G-protein coupled receptor family. This protein is one of four receptors identified for prostaglandin E2 (PGE2). This receptor may have many biological functions, which involve digestion, nervous system, kidney reabsorption, and uterine contraction activities. Studies of the mouse counterpart suggest that this receptor may also mediate adrenocorticotropic hormone response as well as fever generation in response to exogenous and endogenous stimuli. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2009]
PTGER3 (Prostaglandin E Receptor 3) is a Protein Coding gene. Diseases associated with PTGER3 include Ocular Hyperemia and Antenatal Bartter Syndrome. Among its related pathways are Eicosanoid ligand-binding receptors and Signaling by GPCR. Gene Ontology (GO) annotations related to this gene include G protein-coupled receptor activity and prostaglandin E receptor activity. An important paralog of this gene is PTGFR.
Prostanoid receptors are activated by the endogenous ligands prostaglandin (PG) D2, PGE2, PGF2alpha, PGH2, prostacyclin (PGI2) and thromboxane A2. Cyclooxygenase (COX) converts arachidonic acid to PGH2, from which the other prostaglandins are synthesized.
GeneHancer (GH) Identifier | GH Type | GH Score |
GH Sources | Gene Association Score | Total Score | TSS distance (kb) | Number of Genes Away | Size (kb) | Transcription Factor Binding Sites |
Gene Targets |
---|---|---|---|---|---|---|---|---|---|---|
GH01J071044 | Promoter/Enhancer | 1.7 | EPDnew Ensembl ENCODE dbSUPER | 633.3 | +1.2 | 1167 | 3.5 | HNRNPL JUND FOXA1 ZIC2 PKNOX1 EZH2 DPF2 HDAC1 ZNF600 SOX6 | PTGER3 ZRANB2-AS1 ENSG00000269933 CTH | |
GH01J070674 | Enhancer | 1.1 | Ensembl ENCODE | 18 | +372.1 | 372095 | 1.8 | SIX5 LEF1 IKZF1 JUND DDX20 MTA2 PHF21A PKNOX1 ZNF24 MTA1 | PTGER3 ZRANB2-AS1 MIR186 ZRANB2 SRSF11 CASP3P1 LINC01788 CTH | |
GH01J071037 | Enhancer | 0.5 | dbSUPER | 35.3 | +9.5 | 9515 | 2.6 | IKZF1 PKNOX1 CEBPG CEBPB CBFA2T3 | PTGER3 ZRANB2-AS1 lnc-CTH-13 CTH | |
GH01J071016 | Enhancer | 0.4 | Ensembl dbSUPER | 33.9 | +30.0 | 30015 | 0.4 | ZNF184 | PTGER3 ENSG00000235782 MIR186 ZRANB2 lnc-ZRANB2-2 lnc-CTH-13 lnc-CTH-14 CTH | |
GH01J070978 | Enhancer | 0.6 | Ensembl | 24.3 | +67.9 | 67915 | 3 | TEAD4 ZNF512 ZNF316 MAFF MAFK MAFG CEBPG SPI1 ATF4 ZNF366 | PTGER3 ENSG00000235782 lnc-CTH-12 ENSG00000269933 lnc-CTH-14 CTH |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0004930 | G protein-coupled receptor activity | IEA | -- |
GO:0004955 | prostaglandin receptor activity | IEA | -- |
GO:0004957 | prostaglandin E receptor activity | TAS,NAS | 9073510 |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005623 | cell | IEA | -- |
GO:0005635 | nuclear envelope | TAS | 10336471 |
GO:0005886 | plasma membrane | TAS | -- |
GO:0005887 | integral component of plasma membrane | TAS | 8307176 |
GO:0016020 | membrane | IEA | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Peptide ligand-binding receptors | ||
2 | Eicosanoid ligand-binding receptors | ||
3 | Signaling by GPCR | ||
4 | Calcium signaling pathway | ||
5 | cAMP signaling pathway |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006954 | inflammatory response | IBA | 21873635 |
GO:0007165 | signal transduction | IEA | -- |
GO:0007186 | G protein-coupled receptor signaling pathway | TAS | -- |
GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | IBA | 21873635 |
GO:0007200 | phospholipase C-activating G protein-coupled receptor signaling pathway | IBA | 21873635 |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Bimatoprost | Approved, Investigational | Pharma | Agonist, Full agonist, Target, agonist | 145 | ||
Iloprost | Approved, Investigational | Pharma | Agonist, Full agonist, agonist | Prostacyclin (PGI2) analog, Others | 93 | |
Dinoprostone | Approved | Pharma | Target, agonist, antagonist | activates the PGE2 receptor, Major endogenous prostanoid | 137 | |
Misoprostol | Approved | Pharma | Target, agonist | 412 | ||
Treprostinil | Approved, Investigational | Pharma | Agonist, Full agonist, agonist | 109 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
L-826266 (sodium salt) |
|
Antagonist |
|
|||
sodium |
|
7440-23-5 |
|
|||
(+-)-Cloprostenol sodium salt |
|
55028-72-3 |
|
|
Compound | Action | Cas Number |
---|---|---|
(+-)-Cloprostenol sodium salt | Water-soluble PGF2alpha analog and potent FP receptor agonist | 55028-72-3 |
BMY 45778 | Non-prostanoid prostacyclin IP receptor partial agonist | 152575-66-1 |
Iloprost | Prostacyclin (PGI2) analog | 78919-13-8 |
Prostaglandin E2 | Major endogenous prostanoid | 363-24-6 |
U 46619 | Potent, stable thromboxane A2 (TP) receptor agonist | 56985-40-1 |
Compound | Action | Cas Number |
---|---|---|
Alprostadil | 745-65-3 | |
Bimatoprost | 155206-00-1 | |
BMY 45778 | Type I IL-1 receptor antagonist | 152575-66-1 |
ExUns: | 1a | · | 1b | · | 1c | ^ | 2a | · | 2b | ^ | 3 | ^ | 4 | ^ | 5 | ^ | 6 | ^ | 7 | ^ | 8 | ^ | 9 | ^ | 10 | ^ | 11a | · | 11b |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | - | - | - | |||||||||||||||||||||||
SP2: | - | - | - | - | - | - | |||||||||||||||||||||||
SP3: | - | - | |||||||||||||||||||||||||||
SP4: | - | - | - | - | - | - | - | ||||||||||||||||||||||
SP5: | - | ||||||||||||||||||||||||||||
SP6: | - | - | - | - | - | - | - | - | - | ||||||||||||||||||||
SP7: |
This gene was present in the common ancestor of chordates.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | PTGER3 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | PTGER3 30 |
|
||
Cow (Bos Taurus) |
Mammalia | PTGER3 30 31 |
|
OneToOne | |
Mouse (Mus musculus) |
Mammalia | Ptger3 30 17 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Ptger3 30 |
|
||
Oppossum (Monodelphis domestica) |
Mammalia | -- 31 |
|
OneToMany | |
-- 31 |
|
OneToMany | |||
Chicken (Gallus gallus) |
Aves | PTGER3 30 |
|
||
EP3 31 |
|
OneToOne | |||
Lizard (Anolis carolinensis) |
Reptilia | PTGER3 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | ptger3 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | LOC100000544 30 |
|
||
ptger3 31 |
|
OneToOne |
SNP ID | Clinical significance and condition | Chr 01 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
770488 | Likely Benign: not provided | 70,952,978(-) | TG/T | FRAMESHIFT_VARIANT,THREE_PRIME_UTR_VARIANT,INTRON_VARIANT | |
777911 | Benign: not provided | 71,047,467(-) | G/C | NON_CODING_TRANSCRIPT_VARIANT,SYNONYMOUS_VARIANT | |
rs13306014 | - | p.Asn366Ser | |||
rs13306020 | - | p.Thr319Met | |||
rs5670 | - | p.Met169Leu |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
dgv177n100 | CNV | loss | 25217958 |
dgv22e214 | CNV | loss | 21293372 |
esv2138101 | CNV | deletion | 18987734 |
esv2672048 | CNV | deletion | 23128226 |
esv2762149 | CNV | loss | 21179565 |
esv3342245 | CNV | insertion | 20981092 |
esv3577913 | CNV | loss | 25503493 |
esv3577914 | CNV | loss | 25503493 |
esv3586370 | CNV | loss | 21293372 |
esv3586371 | CNV | loss | 21293372 |
esv3893657 | CNV | loss | 25118596 |
esv994407 | CNV | insertion | 20482838 |
nsv461851 | CNV | gain | 19166990 |
nsv516212 | CNV | loss | 19592680 |
nsv546471 | CNV | loss | 21841781 |
nsv546472 | CNV | gain | 21841781 |
nsv546473 | CNV | gain | 21841781 |
nsv830148 | CNV | gain | 17160897 |
Disorder | Aliases | PubMed IDs |
---|---|---|
ocular hyperemia |
|
|
antenatal bartter syndrome |
|
|
skin amelanotic melanoma |
|
|
primary hypertrophic osteoarthropathy |
|
|
severe cutaneous adverse reaction |
|
|